SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-020421
Filing Date
2023-01-31
Accepted
2023-01-31 16:46:04
Documents
14
Period of Report
2023-01-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d421995d8k.htm   iXBRL 8-K 26651
2 EX-99.1 d421995dex991.htm EX-99.1 10039
6 GRAPHIC g421995g0131141515530.jpg GRAPHIC 4500
  Complete submission text file 0001193125-23-020421.txt   173374

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstx-20230126.xsd EX-101.SCH 2837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstx-20230126_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstx-20230126_pre.xml EX-101.PRE 11698
8 EXTRACTED XBRL INSTANCE DOCUMENT d421995d8k_htm.xml XML 3478
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39376 | Film No.: 23573117
SIC: 2836 Biological Products, (No Diagnostic Substances)